Phase2 Launches Pharma iCX: Delivering Impactful, Compliant Digital Solutions for Pharmaceutical Companies
Phase2 Launches Pharma iCX: Delivering Impactful, Compliant Digital Solutions for Pharmaceutical Companies
Lindsey Di Costa | Marketing Communications Manager
April 24, 2025
The new platform builds on Health iCX success, combining consumer engagement with regulatory compliance for healthcare professionals and patients.
Arlington, VA, April 24, 2025 – Phase2, a leading digital agency with deep healthcare ecosystem expertise, today announced the launch of Pharma iCX, an intelligent customer experience platform designed for pharmaceutical organizations. This expansion of Phase2's iCX suite applies proven methodologies from the successful Health iCX platform to address the distinct needs of pharmaceutical communications.
Pharma iCX solves key challenges pharmaceutical companies face in creating compliant, information-rich digital platforms. The pre-configured solution enables rapid deployment of compelling digital destinations where audiences can quickly find, understand, and act on critical information. The platform specifically supports pharmaceutical needs including merger and acquisition onboarding, PRC to FDA approval processes, and seamless management of both HCP and patient-facing content.
Key features of Pharma iCX include:
- Compelling Content Frameworks: Creative templates that drive message retention and action while maintaining regulatory compliance.
- M&A Digital Integration: Streamlined processes for rapidly harmonizing digital assets during mergers and acquisitions.
- Regulatory Pathway Support: Specialized workflows supporting the journey from PRC to FDA approval throughout product development cycles.
- Dual Audience Engagement: Unified platform for managing both HCP and patient-facing content with tailored messaging.
- AI-Enhanced Compliance: Artificial intelligence tools that maintain regulatory compliance while identifying opportunities for creative engagement.
"Pharmaceutical organizations need digital solutions that combine nimble, creative engagement practices with unwavering compliance," said Emily White, SVP, Marketing at Phase2. "Pharma iCX applies our healthcare ecosystem expertise to address specific pharmaceutical needs, empowering companies to deliver influential, compliant information that drives action from both healthcare professionals and patients."
Pharma iCX can be built on robust platforms including Drupal, Sitecore, Adobe Experience Manager, and Optimizely. It features specialized tools for industry-specific integrations, creative content development, regulatory document management, and audience-specific messaging. The platform complements regulatory submission systems and marketing automation tools, ensuring speed to market while maintaining compliance.
Early adopters report significant improvements in specialty drug education, message comprehension and audience engagement, particularly around product launches and merger activities. The platform's approach to compliance has proven valuable for delivering effective information across audience segments while respecting regulatory boundaries.
For more information about Phase2’s iCX suite and to schedule a demo, please reach out below.
About Phase2
Phase2 is a digital experience agency dedicated to advancing the human experience through technology. Specializing in healthcare, Phase2 combines data-driven insights with innovative solutions to create impactful digital products. With a commitment to excellence and a passion for improving patient outcomes, Phase2 partners with organizations to navigate the complexities of digital transformation.
Media Inquiries
Lindsey Di Costa
Marketing Communications Manager, Phase2
ldicosta@phase2.io